163 results about "Mouth/Throat" patented technology

Devices, systems and methods for performing image guided interventional and surgical procedures, including various procedures to treat sinusitis and other disorders of the paranasal sinuses, ears, nose or throat.

Sinusitis and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches with flexible or rigid instruments. Various methods and devices are used for remodeling or changing the shape, size or configuration of a sinus ostium or duct or other anatomical structure in the ear, nose or throat; implanting a device, cells or tissues; removing matter from the ear, nose or throat; delivering diagnostic or therapeutic substances or performing other diagnostic or therapeutic procedures. Introducing devices (e.g., guide catheters, tubes, guidewires, elongate probes, other elongate members) may be used to facilitate insertion of working devices (e.g. catheters e.g. balloon catheters, guidewires, tissue cutting or remodeling devices, devices for implanting elements like stents, electrosurgical devices, energy emitting devices, devices for delivering diagnostic or therapeutic agents, substance delivery implants, scopes etc.) into the paranasal sinuses or other structures in the ear, nose or throat. Specific devices (e.g., tubular guides, guidewires, balloon catheters, tubular sheaths) are provided as are methods for manufacturing and using such devices to treat disorders of the ear, nose or throat.

Devices, systems and methods useable for dilating the ostia of paranasal sinuses and/or other passageways within the ear, nose or throat. A dilation catheter device and system is constructed in a manner that facilitates ease of use by the operator and, in at least some cases, allows the dilation procedure to be performed by a single operator. Additionally, the dilation catheter device and system may be useable in conjunction with an endoscope and/or a fluoroscope to provide for easy manipulation and positioning of the devices and real time visualization of the entire procedure or selected portions thereof. In some embodiments, an optional handle may be used to facilitate grasping or supporting a device of the present invention as well as another device (e.g., an endoscope) with a single hand.

When there is an obstruction to the passage of air through the back of the mouth and nose, the soft palate and the bell collide, producing a vibration called snoring. There are various ways of reducing or eliminating snoring, nasal masks introducing air pressure to the throat (CPAP), surgery of the throat (OPPBA) and devices that are introduced into the mouth to cause a mandibular advancement what increases the oropharyngeal area, improving ventilation, among other solutions. The present invention disclosure an intraocclusal removable device in the form of a “U” that is placed covering all of the upper jaw teeth, wherein two steps, one in each extreme of the lower part of the element, which impede the mandible be closed completely on its normal occlusion, forcing it to produce a forward displacement of the lower jaw.

An apparatus and method are described that uses fractional light based treatment to shrink soft tissue in the mouth or throat to reduce obstruction of the airways for patients suffering from obstructive sleep apnea. A light delivery probe with scanning optics can be used to deliver treatment. Cooling systems can be added to reduce damage to epithelial layers of tissue. Light based treatment can be nonablative or ablative and is preferably performed with a laser.

The present invention is directed to a mucoadhesive delivery system for the local or systemic administration of a pharmaceutical agent. The delivery system of the invention effectively and facilely enables transport of the pharmaceutical agent through mucosal membranes and into the vasculattire of the mucosa. The delivery system includes an at least partially water soluble bioadhesive layer and an at least partially water soluble backing layer. Incorporated within either or both of these layers are the pharmaceutical agent and a mucosal penetration enhancing agent. The mucosal penetration enhancing agent displays localized tissue irritation properties. The mucoadhesive delivery system may be in the form of a gel, film, disc or patch. It may be applied to any mucosal membrane of a patient including but not limited to those of the buccal and nasal cavities, throat, eye, vagina, alimentary tract and peritoneum.

An anti-cough, anti-tussive, and throat soothing synergistic herbal formulation comprising of an extract of Piper cubeba, Glycyrrhiza glabra, Acorus calamus Alpinia galanga, Zingiber officinale and pharmaceutically acceptable additives as a syrup, lozenges or chewable tablets for preventing cracking of voice, dryness of mouth and toning of voice, vocal cord; the present invention also provides a method of preparation of this formulation.

The present invention provides methods and compositions for treating and preventing conditions characterized by infection and/or inflammation, especially of the eyes, ears, nose, and/or throat. The methods of the invention involve administering hypohalous acid to the patient, such as in the form of a composition described herein.

The present invention is the universal unmedicamental system to treat the snore and obstructive sleep apnea and recover of the normal breathing during sleep. The invention includes the device, which ensures the fixation of the tongue in a putting forward beyond the mouth position. As a result, the tongue's pharyngeal part pushes forward in the mouth, releasing besides the throat and excluding the tongue from a system of obstruction to the air's passing through the throat. This increases the throat's capacity, depriving the other throat's structures of the possibility to provoke the partial or complete obstruction to the air's passing through the throat during the physiological process of breathing in the time of the sleep.

To deliver a medication and its active ingredients to the esophagus, a nasal irrigator, which is capable of delivering medicated fluid that coats the whole nasal and paranasal sinus cavities, is used. The nasal irrigator forces an aerosol mist of the medicated fluid into the nasal cavity above the inferior turbinate, independent of a user's breathing in. Mucociliary clearance from the nasal cavity then delivers the medication to the throat and it is then topically introduced onto the esophagus over an extended period of time.

In certain embodiments, the present invention is directed to the use of soothing agents to relieve mild irritation and/or enhance the overall soothing, comfort or refreshing feel of mucosal membranes of the eye, oral cavity, otic, nose, throat or vaginal area. The present invention further relates to compositions, articles and methods for masking or reducing the irritant properties of sensory compounds, such as terpenes and/or phenolic agents.

Methods, devices and systems for the treatment of nasal valve collapse or other conditions of the ear, nose or throat.

This inhaler has a drug vial part and diverging cone shaped mouthpiece (11). Drug vial (7) (with needed drugs in propellant, cosolvents) has a spray rod (8) fitting into a socket (9) with a nozzle (10) leading into the mouthpiece. Mouthpiece (11) has a small air hole (12) with a baffle (13) creating audible sound, for early inhalation triggering. A filter (14) covers the air hole. A dose counter (15) records use. The long mouth piece is kept in mouth, air inhaled, alerting sound is heard, drug vial is pressed, the spray is released at back of throat with longer, deeper and slow inhalation for more lung drug deposit and relief with clean filtered air and dose counter! Modified Insulin (protein) inhaler socket has separate propellant (7) and insulin vials (18)! Insulin vial has a piston (19) and valved exit (20) fitting the socket, before propellant vial. Insulin piston fills needed dose in socket, inhaled, propellant vial is pressed, and insulin spray fills lungs!

In one embodiment, a device for reducing or eliminating snoring by providing easy inhalation through the mouth and slightly restricted exhalation allowed only through the nose. This results in positive airway pressure, keeping the soft tissues of the mouth and throat sufficiently separate to discourage snoring.

The present disclosure describes pharmaceutical compositions and methods for reducing duration, intensity, and/or bothersomeness of common colds in humans and for reducing severity or duration of common cold symptoms such as nasal congestion, runny nose, watery eyes, dry/scratchy throat and sneezing in humans exhibiting such symptoms. The compositions herein comprise extracts of at least one of Luffa Operculata (L. operculata), S. officinale (V. sabadilla), and Galphimia Glauca (G. glauca) in a pharmaceutically acceptable carrier, and in various embodiments, comprise a mixture of all three Luffa Operculata (L. operculata) 10% extract MT, S. officinale (V. sabadilla) 3× extract, and Galphimia Glauca (G. glauca) 10% extract MT in a pharmaceutically acceptable carrier.